Botrychium ternatum (Thunb) Sw.对大鼠中细胞染色体P450活性的影响
Jiange Yao1, Liming Hu2, Quan Zhou3
1Department of Outpatient, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Pharmacology research & perspectives
|November 19, 2025
概括
植物 (Botrychium Ternatum,BT) 显著影响细胞P450 (CYP) 酶,增加其表达和药物清除. 建议在使用BT与CYP代谢药物时进行剂量调整.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 草药研究 草药研究
背景情况:
- 药物相互作用经常来自细胞P450 (CYP) 酶活性.
- 了解传统药物对CYP酶的影响对于安全的同时使用至关重要.
研究的目的:
- 为了研究中国草药Botrychium Ternatum (BT) 对六种关键CYP酶的活性和表达的影响.
- 评估BT对大鼠肝功能和药物代谢的影响.
主要方法:
- 12只健康的雄性Sprague-Dawley大鼠被分为对照组和接受BT治疗的组.
- 进行了试验药物,并使用UPLC-MS/MS.分析了血度.
- 用实时光定量PCR量化酶表达水平,并评估血清生物化学指标.
主要成果:
- BT的使用导致曲线下的面积 (AUC) 降低,探针药物的清除率提高.
- BT显著上调了六个研究的CYP酶的表达.
- BT治疗降低了阿斯巴酸氨基转移酶水平,这表明它对肝细胞具有潜在的保护作用.
结论:
- 植物 (Botrychium Ternatum,BT) 增强了细胞P450 (CYP) 酶的活性和表达.
- 患者同时使用BT和由CYP酶代谢的药物可能需要调整剂量.
- 为了临床安全,需要对BT的药理动力学相互作用进行进一步的研究.
更多相关视频
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
14.2K
09:37Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
15.4K
相关概念视频
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
663
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
663
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
204
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
204
